IMA
HEALTHCAREIkena Oncology Inc
$6.08+0.25 (+4.29%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving IMA Today?
No stock-specific AI insight has been generated for IMA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.94$18.00
$6.08
Fundamentals
Market Cap$69M
P/E Ratio—
EPS$-9.64
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin—
Debt / Equity—
Trading
Volume17K
Avg Volume (10D)—
Shares Outstanding11.3M
IMA News
14 articles- ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program UpdateYahoo Finance·May 7, 2026
- ImageneBio Announces $30 Million Private PlacementYahoo Finance·Apr 13, 2026
- Image Resources NL (ASX:IMA) Is About To Turn The CornerYahoo Finance·Apr 1, 2026
- Imax announces $28M opening weekend for Amazon/MGM/s ‘Project Hail Mary’Yahoo Finance·Mar 24, 2026
- ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Mar 17, 2026
- ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company UpdateYahoo Finance·Mar 10, 2026
- ImageneBio to Participate in Leerink Global Healthcare ConferenceYahoo Finance·Feb 26, 2026
- ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical OfficerYahoo Finance·Feb 10, 2026
- ImageneBio Insider Confidence Rewarded, Stock Hits US$76m Market CapYahoo Finance·Dec 31, 2025
- Here's Why We're Watching ImageneBio's (NASDAQ:IMA) Cash Burn SituationYahoo Finance·Nov 15, 2025
- ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management TeamYahoo Finance·Nov 12, 2025
- ImageneBio to Participate in Fourth Quarter 2025 Investor ConferencesYahoo Finance·Nov 6, 2025
- Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to TradeYahoo Finance·Aug 5, 2025
- Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 MillionYahoo Finance·Jul 25, 2025
All 14 articles loaded
Price Data
Open$5.94
Previous Close$5.83
Day High$6.08
Day Low$5.93
52 Week High$18.00
52 Week Low$3.94
52-Week Range
$3.94$18.00
$6.08
Fundamentals
Market Cap$69M
P/E Ratio—
EPS$-9.64
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin—
Debt / Equity—
Trading
Volume17K
Avg Volume (10D)—
Shares Outstanding11.3M
About Ikena Oncology Inc
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—